Here, we examined the correlation between IL20RB expression and clinical characteristics of pancreatic cancer, and explored the underlying mechanisms of how IL20RB modulates pancreatic cancer stemness and chemotherapy resistance. This evidence concerns the gene IL20RB and familial pancreatic carcinoma.